Sagoh

Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management

• Breast Cancer Surgery and Reconstruction

Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management

Sagoh September 19, 2026

For decades, the mention of Botulinum toxin type A—widely recognized by its commercial name, Botox—has been synonymous...

Read More Read more about Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management

Decoding the Pandemic: How a Reunion of MIT Alumni Revolutionized Genomic Epidemiology

• Genomics and Precision Medicine

Decoding the Pandemic: How a Reunion of MIT Alumni Revolutionized Genomic Epidemiology

Sagoh September 18, 2026

Highlights A Strategic Reunion: Mid-2020 saw the convergence of three former MIT collaborators—Patrick Varilly, Pardis Sabeti, and...

Read More Read more about Decoding the Pandemic: How a Reunion of MIT Alumni Revolutionized Genomic Epidemiology

A Decade of Hope: How the Pink Lemonade Stand Challenge Transformed a Childhood Project into a National Movement

• Patient Advocacy and Support

A Decade of Hope: How the Pink Lemonade Stand Challenge Transformed a Childhood Project into a National Movement

Sagoh September 14, 2026

NATIONWIDE — In the landscape of American philanthropy, few images are as iconic as a child’s lemonade...

Read More Read more about A Decade of Hope: How the Pink Lemonade Stand Challenge Transformed a Childhood Project into a National Movement

Landmark Study Unveils Breakthrough in Targeting Aggressive Prostate Cancer with Combination Therapy

• Medical Research and Clinical Trials

Landmark Study Unveils Breakthrough in Targeting Aggressive Prostate Cancer with Combination Therapy

Sagoh September 12, 2026

LONDON, UK – In a significant stride towards personalized medicine for advanced prostate cancer, an international Phase...

Read More Read more about Landmark Study Unveils Breakthrough in Targeting Aggressive Prostate Cancer with Combination Therapy

FDA Approves Gedatolisib (Revtorpyk®): A Paradigm Shift in the Treatment of HR+/HER2- Metastatic Breast Cancer

• Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk®): A Paradigm Shift in the Treatment of HR+/HER2- Metastatic Breast Cancer

Sagoh September 12, 2026

The landscape of advanced breast cancer treatment underwent a significant transformation this week as the U.S. Food...

Read More Read more about FDA Approves Gedatolisib (Revtorpyk®): A Paradigm Shift in the Treatment of HR+/HER2- Metastatic Breast Cancer

From Radical Surgery to Molecular Precision: The Multi-Millennial Evolution of Breast Cancer Treatment

• Patient Advocacy and Support

From Radical Surgery to Molecular Precision: The Multi-Millennial Evolution of Breast Cancer Treatment

Sagoh September 11, 2026

Breast cancer is no longer viewed as a singular, monolithic disease, but as a complex mosaic of...

Read More Read more about From Radical Surgery to Molecular Precision: The Multi-Millennial Evolution of Breast Cancer Treatment

Federal Vaccine Policy Shift: Implications as Measles Cases Reach 35-Year High

• Treatment Innovations

Federal Vaccine Policy Shift: Implications as Measles Cases Reach 35-Year High

Sagoh September 10, 2026

As the United States grapples with a public health landscape marked by the highest incidence of measles...

Read More Read more about Federal Vaccine Policy Shift: Implications as Measles Cases Reach 35-Year High

FDA Clinical Hold Hits Biohaven’s Epilepsy Program: A New Hurdle for the Biotech’s Pipeline

• Treatment Innovations

FDA Clinical Hold Hits Biohaven’s Epilepsy Program: A New Hurdle for the Biotech’s Pipeline

Sagoh September 10, 2026

By Delilah Alvarado | September 10, 2026 The pharmaceutical landscape is often defined by its volatility, but...

Read More Read more about FDA Clinical Hold Hits Biohaven’s Epilepsy Program: A New Hurdle for the Biotech’s Pipeline

Empowering Change: How Organizations Can Drive Impact During Breast Cancer Awareness Month

• Survivorship and Post-Treatment

Empowering Change: How Organizations Can Drive Impact During Breast Cancer Awareness Month

Sagoh September 9, 2026

As October approaches, businesses, educational institutions, and community groups across the globe prepare to turn their attention...

Read More Read more about Empowering Change: How Organizations Can Drive Impact During Breast Cancer Awareness Month

Novartis Faces Strategic Reckoning After High-Stakes Clinical Trial Failure

• Treatment Innovations

Novartis Faces Strategic Reckoning After High-Stakes Clinical Trial Failure

Sagoh September 9, 2026

In a development that has sent shockwaves through the biopharmaceutical sector, Swiss pharmaceutical giant Novartis announced this...

Read More Read more about Novartis Faces Strategic Reckoning After High-Stakes Clinical Trial Failure